Revolution Medicines is a U.S.-based biotechnology company focused on developing innovative cancer therapies targeting specific proteins and signaling pathways associated with cancer development. The company specializes in identifying and modulating new therapeutic targets, particularly oncogenic proteins that are key to the growth and spread of cancer cells. Revolution Medicines concentrates on developing drugs that could offer a new approach to cancer treatment and improve outcomes for patients suffering from various types of cancer.